OncoForma
1 known investors
OncoForma grows patient-derived organoids from a patient's tumor cells and screens them against more than 1,800 therapies, combining functional drug testing with genomic data to guide oncologists' treatment decisions. The company serves oncologists and cancer patients and reports delivering results in under three weeks, with a stated focus on Canada.
Investors · 1
Frequently asked questions
- What does OncoForma do?
- OncoForma grows patient-derived organoids from a patient's tumor cells and screens them against more than 1,800 therapies, combining functional drug testing with genomic data to guide oncologists' treatment decisions. The company serves oncologists and cancer patients and reports delivering results in under three weeks, with a stated focus on Canada.
- Who are OncoForma's investors?
- OncoForma's investors include Startup TNT.